ADMA Biologics, Inc. (ADMA)
Health Care ยท Biological Products, (No Diagnostic Substances)
ADMA Biologics, Inc. (ADMA) is listed on Nasdaq, where its shares have traded since October 17, 2013. SentiSense covers ADMA Biologics, Inc. in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances). Adam S. Grossman is its chief executive officer. The company reports 647 employees, and its corporate website is www.admabiologics.com.
About ADMA Biologics, Inc.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Latest reported results
ADMA Biologics, Inc. reported revenue of $124.4 million for Q2 FY2026, up 2.0% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 312 institutions reported holding ADMA, with 203.2 million shares worth $1.7 billion in aggregate. The largest reported holders were BlackRock, Vanguard and State Street.
More on ADMA
- ADMA sentiment: whether news and social coverage of ADMA Biologics, Inc. leans bullish or bearish, and the stories driving it.
- ADMA ownership: all 312 reporting institutions, plus insider and congressional trades.
- ADMA financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
Frequently asked questions
What does ADMA Biologics, Inc. do?
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.
What sector is ADMA in?
SentiSense classifies ADMA Biologics, Inc. in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances).
Where does ADMA stock trade?
ADMA Biologics, Inc. (ADMA) is listed on Nasdaq, where its shares have traded since October 17, 2013.
Who is the CEO of ADMA Biologics, Inc.?
Adam S. Grossman is the chief executive officer of ADMA Biologics, Inc..